267 related articles for article (PubMed ID: 20095972)
1. Polyamine analogues targeting epigenetic gene regulation.
Huang Y; Marton LJ; Woster PM; Casero RA
Essays Biochem; 2009 Nov; 46():95-110. PubMed ID: 20095972
[TBL] [Abstract][Full Text] [Related]
2. The re-expression of the epigenetically silenced e-cadherin gene by a polyamine analogue lysine-specific demethylase-1 (LSD1) inhibitor in human acute myeloid leukemia cell lines.
Murray-Stewart T; Woster PM; Casero RA
Amino Acids; 2014 Mar; 46(3):585-94. PubMed ID: 23508577
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes.
Huang Y; Greene E; Murray Stewart T; Goodwin AC; Baylin SB; Woster PM; Casero RA
Proc Natl Acad Sci U S A; 2007 May; 104(19):8023-8. PubMed ID: 17463086
[TBL] [Abstract][Full Text] [Related]
4. Oligoamine analogues in combination with 2-difluoromethylornithine synergistically induce re-expression of aberrantly silenced tumour-suppressor genes.
Wu Y; Steinbergs N; Murray-Stewart T; Marton LJ; Casero RA
Biochem J; 2012 Mar; 442(3):693-701. PubMed ID: 22132744
[TBL] [Abstract][Full Text] [Related]
5. Novel oligoamine analogues inhibit lysine-specific demethylase 1 and induce reexpression of epigenetically silenced genes.
Huang Y; Stewart TM; Wu Y; Baylin SB; Marton LJ; Perkins B; Jones RJ; Woster PM; Casero RA
Clin Cancer Res; 2009 Dec; 15(23):7217-28. PubMed ID: 19934284
[TBL] [Abstract][Full Text] [Related]
6. Polyamine analogs modulate gene expression by inhibiting lysine-specific demethylase 1 (LSD1) and altering chromatin structure in human breast cancer cells.
Zhu Q; Huang Y; Marton LJ; Woster PM; Davidson NE; Casero RA
Amino Acids; 2012 Feb; 42(2-3):887-98. PubMed ID: 21805138
[TBL] [Abstract][Full Text] [Related]
7. Polyamine-based analogues as biochemical probes and potential therapeutics.
Boncher T; Bi X; Varghese S; Casero RA; Woster PM
Biochem Soc Trans; 2007 Apr; 35(Pt 2):356-63. PubMed ID: 17371278
[TBL] [Abstract][Full Text] [Related]
8. Human histone demethylase LSD1 reads the histone code.
Forneris F; Binda C; Vanoni MA; Battaglioli E; Mattevi A
J Biol Chem; 2005 Dec; 280(50):41360-5. PubMed ID: 16223729
[TBL] [Abstract][Full Text] [Related]
9. Chromatin remodeling by polyamines and polyamine analogs.
Pasini A; Caldarera CM; Giordano E
Amino Acids; 2014 Mar; 46(3):595-603. PubMed ID: 23836422
[TBL] [Abstract][Full Text] [Related]
10. Novel polyamine-based Histone deacetylases-Lysine demethylase 1 dual binding inhibitors.
Milelli A; Marchetti C; Turrini E; Catanzaro E; Mazzone R; Tomaselli D; Fimognari C; Tumiatti V; Minarini A
Bioorg Med Chem Lett; 2018 Apr; 28(6):1001-1004. PubMed ID: 29496367
[TBL] [Abstract][Full Text] [Related]
11. A novel mammalian flavin-dependent histone demethylase.
Karytinos A; Forneris F; Profumo A; Ciossani G; Battaglioli E; Binda C; Mattevi A
J Biol Chem; 2009 Jun; 284(26):17775-82. PubMed ID: 19407342
[TBL] [Abstract][Full Text] [Related]
12. Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression.
Lan F; Collins RE; De Cegli R; Alpatov R; Horton JR; Shi X; Gozani O; Cheng X; Shi Y
Nature; 2007 Aug; 448(7154):718-22. PubMed ID: 17687328
[TBL] [Abstract][Full Text] [Related]
13. Polyamine-based small molecule epigenetic modulators.
Sharma SK; Hazeldine S; Crowley ML; Hanson A; Beattie R; Varghese S; Senanayake TM; Hirata A; Hirata F; Huang Y; Wu Y; Steinbergs N; Murray-Stewart T; Bytheway I; Casero RA; Woster PM
Medchemcomm; 2012; 3(1):14-21. PubMed ID: 23293738
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle strategies for cancer therapeutics: Nucleic acids, polyamines, bovine serum amine oxidase and iron oxide nanoparticles (Review).
Agostinelli E; Vianello F; Magliulo G; Thomas T; Thomas TJ
Int J Oncol; 2015 Jan; 46(1):5-16. PubMed ID: 25333509
[TBL] [Abstract][Full Text] [Related]
15. Significance of targeting polyamine metabolism as an antineoplastic strategy: unique targets for polyamine analogues.
Casero RA; Frydman B; Stewart TM; Woster PM
Proc West Pharmacol Soc; 2005; 48():24-30. PubMed ID: 16416654
[TBL] [Abstract][Full Text] [Related]
16. LSD1 coordinates with the SIN3A/HDAC complex and maintains sensitivity to chemotherapy in breast cancer.
Yang Y; Huang W; Qiu R; Liu R; Zeng Y; Gao J; Zheng Y; Hou Y; Wang S; Yu W; Leng S; Feng D; Wang Y
J Mol Cell Biol; 2018 Aug; 10(4):285-301. PubMed ID: 29741645
[TBL] [Abstract][Full Text] [Related]
17. Design of polyamine-based therapeutic agents: new targets and new directions.
Senanayake MD; Amunugama H; Boncher TD; Casero RA; Woster PM
Essays Biochem; 2009 Nov; 46():77-94. PubMed ID: 20095971
[TBL] [Abstract][Full Text] [Related]
18. New roles of flavoproteins in molecular cell biology: histone demethylase LSD1 and chromatin.
Forneris F; Battaglioli E; Mattevi A; Binda C
FEBS J; 2009 Aug; 276(16):4304-12. PubMed ID: 19624733
[TBL] [Abstract][Full Text] [Related]
19. Re-programing Chromatin with a Bifunctional LSD1/HDAC Inhibitor Induces Therapeutic Differentiation in DIPG.
Anastas JN; Zee BM; Kalin JH; Kim M; Guo R; Alexandrescu S; Blanco MA; Giera S; Gillespie SM; Das J; Wu M; Nocco S; Bonal DM; Nguyen QD; Suva ML; Bernstein BE; Alani R; Golub TR; Cole PA; Filbin MG; Shi Y
Cancer Cell; 2019 Nov; 36(5):528-544.e10. PubMed ID: 31631026
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of polyamine analogs in cancer cells.
Huang Y; Pledgie A; Casero RA; Davidson NE
Anticancer Drugs; 2005 Mar; 16(3):229-41. PubMed ID: 15711175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
